Pfizer

Icon CEO Peter Gray to step down after nine years; CFO Ciaran Murray takes the helm as of Oct. 1

Monday, September 12, 2011 08:02 AM

Peter Gray, CEO of Icon since 2002, will step down as of Oct. 1. The announcement, which came last week, surprised many in the industry.  Icon’s board has appointed Ciaran Murray, who has been Icon’s CFO for the last six years, to succeed Gray as CEO.

More... »

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

Pfizer to create 400 jobs in Massachusetts

Friday, September 2, 2011 10:50 AM

Pfizer is gobbling up some prime biotech real estate in Cambridge, MA. The New York-based pharma company is adding space for 400 employees at the heart of the biotech R&D hub in Kendall Square, according to Xconomy Boston.

More... »

Roche CEO says diagnostics will maintain its lead in targeted drugs

Thursday, September 1, 2011 02:15 PM

Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine, according to Reuters.

More... »

The Research Network operates from former Pfizer site

Thursday, September 1, 2011 10:25 AM

A company set up by a group of former Pfizer employees is one of the first businesses to be based at the east Kent site which Pfizer is leaving, according to BBC Mobile.

More... »

DVS Sciences raises $14 million, largest round in Canada life sciences, to expand CyTOF sales

Monday, August 29, 2011 08:00 AM

DVS Sciences, which invented and manufactures an instrument enabling biomarker analysis for scientific research, clinical trials and personalized medicine, has raised $14.6 million in series A financing. This is the largest venture-backed series A equity raised in Canada’s life sciences and medical technology fields in recent years, and is almost twice the average series A funding in the U.S., the company said.

More... »

Amgen to create hundreds of jobs in Dublin

Tuesday, August 23, 2011 10:26 AM

US drug firm Amgen plans to create 100 high-tech jobs at a new factory in Dublin just months after it saved 280 jobs by taking over a Pfizer plant that was earmarked for closure, according to The Post.

More... »

Ampio names chief business officer

Monday, August 22, 2011 12:50 PM

Ampio Pharmaceuticals has named Deborah Knobelman, Ph.D., chief business officer reporting directly to Ampio CEO, Don Wingerter.

More... »

CROs using backlog numbers to put positive spin on less-than-stellar quarterly earnings reports

Monday, August 22, 2011 08:00 AM

Using backlog allows CROs to put a positive spin on what otherwise might be less-than-stellar earnings; while they may not have had the healthiest quarter—or year—financially, they can showcase all of the work that has been promised over the next few quarters in millions, or billions, of dollars.

More... »

Creabilis expands management team

Thursday, August 18, 2011 10:52 AM

Creabilis has expanded its senior management team. Alex Leech joins as vice president, head of finance and operations, James Sandy as senior vice president, head of development, and Peter Spargo as senior vice president of chemistry manufacturing and controls.

More... »